Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation.
暂无分享,去创建一个
B. Kerem | E. Kerem | F. Ratjen | T. Moraes | M. Wilschanski | T. Gonska | A. Gamliel | J. Reiter | Paul D. W. Eckford | I. Sarouk | G. Livnat | M. Shteinberg | O. Breuer | C. Bartlett | M. Cohen-Cymberknoh | C. Bear | T. Gunawardena | I. Sadras | A. Gileles-Hillel | O. Inbar | N. Stanleigh | M. Cohen | M. Cohen‐Cymberknoh